Profiel
Wendy Chapman, who previously worked at PAREXEL International Corp., YM BioSciences, Inc., and Viventia Biotech, Inc., held senior positions in clinical operations and portfolio direction.
She was also the Chief Operating Officer and Vice President of Clinical Operations at Viventia Biotech, Inc. Most recently, she served as the Senior Vice President of Clinical Operations at Sierra Oncology, Inc. from 2014 to 2022.
Eerdere bekende functies van Wendy Chapman
| Bedrijven | Functie | Einde |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Corporate Officer/Principal | 01-07-2022 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Operationeel Directeur | - |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Health Technology |
Sierra Oncology, Inc.
Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
















